(19)
(11) EP 1 144 638 A2

(12)

(43) Date of publication:
17.10.2001 Bulletin 2001/42

(21) Application number: 99931394.3

(22) Date of filing: 27.07.1999
(51) International Patent Classification (IPC)7C12N 15/31, C12N 15/62, C07K 14/295, C07K 16/12, C12Q 1/68, G01N 33/53, G01N 33/543, G01N 33/569, A61K 39/02, A61K 48/00
(86) International application number:
PCT/IB9901/328
(87) International publication number:
WO 0006/739 (10.02.2000 Gazette 2000/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 27.07.1998 US 94198 P
26.07.1999 US 360707

(71) Applicant: Aventis Pasteur Limited
Toronto,Ontario M2R 3T4 (CA)

(72) Inventors:
  • MURDIN, Andrew, D.
    Newmarket, Ontario L3X 1V2 (CA)
  • OOMEN, Raymond, P.
    Schomberg, Ontario L0G 1T0 (CA)

(74) Representative: MacLean, Martin Robert et al
Mathys & Squire100 Gray's Inn Road
London WC1X 8AL
London WC1X 8AL (GB)

 
Remarks:
WIPO A3 publication data is not currently available.
 


(54) CHLAMYDIA ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF